Page 6 - ப்ளூம்பெர்க் திங்கட்கிழமை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Why is the number of Johnson & Johnson vaccine shots lower than expected? By Martin Finucane Globe Staff,Updated March 1, 2021, 2:34 p.m. Email to a Friend Boxes of the Johnson and Johnson COVID-19 vaccineTimothy D. Easley/Associated Press The Johnson & Johnson vaccine is bringing a new glimmer of hope to a pandemic-weary public, but the number of doses that will initially be delivered in the United States is lower than originally expected. Why? In the company’s $1 billion contract with the federal government in August, the company pledged to have 12 million doses of its vaccine ready by the end of February, ramping up to a total of 100 million doses by the end of June.

United statesWhite houseDistrict of columbiaAlex gorskyJeff zientsSean kirkMike rileyCatalent biologicsFinancial timesNew jersey basedNorth americaBloomberg mondayEmergent biosolutionsஒன்றுபட்டது மாநிலங்களில்வெள்ளை வீடுமாவட்டம் ஆஃப் கொலம்பியா